Equities
People Inc. outlines brand pivot strategy at Oppenheimer conference
Executive leadership details shift toward brand-focused growth and value creation initiatives at annual investor event.
Dauch outlines integration progress at J.P. Morgan auto conference
Visteon CEO discusses accelerating synergies following recent acquisitions and restructuring efforts in the automotive supply sector.
Stoke Therapeutics highlights trial progress at Canaccord conference
Biotech firm Stoke Therapeutics outlines advancing clinical programs and regulatory outlook at investor event.
Anadolu Efes 1H2026 results show diversification offsets Turkey beer decline
Turkey’s beer sales fell 11% in the first half, but Anadolu Efes’ broader portfolio cushioned earnings. Full-year guidance maintained despite regional pressures.
EuroHoldings posts 421% profit jump on tanker pivot
Second-quarter 2026 results reflect shift to tanker shipping, with net income rising to $421 million from $81 million a year earlier.
Fervo reports $55.9M loss in Q2 2026 despite drilling gains
Geothermal energy firm Fervo Energy posted a net loss of $55.9 million for Q2 2026, though operational drilling improvements partially offset the deficit. Revenue and cost details remain undisclosed.
Pandora lifts 2026 outlook on tariff refund, Q2 growth
Danish jeweler raises annual profit forecast after stronger-than-expected second-quarter results and resolution of U.S. tariff dispute.
Nurix Therapeutics shares hit 52-week high of $26.40
The biotech firm's stock surged to its peak level since mid-2023, extending a recent rally amid broader biotech sector strength.
Frasle Mobility posts record 20.4% EBITDA margin in Q2 2026
Automotive components maker Frasle Mobility reported its highest-ever quarterly EBITDA margin, driven by strong operational efficiency and demand recovery.
Cardiff Lexington Q2 2026 slides show expansion despite deeper losses
Company's second-quarter 2026 presentation highlights new market entries and revenue growth, even as net losses widen year-over-year.
Immunome shares hit 52-week high of $27.68
Biotech firm Immunome's stock surged to its highest level in a year amid strong investor interest in small-cap biotech plays.
Red Cat appoints Mitch McDonald as UAS division CEO
Promotion follows expansion in unmanned aerial systems operations for the drone technology firm.
China’s Londian Wason lists on NYSE at $2.01 billion valuation
Chinese manufacturer debuts on the New York Stock Exchange via a $2.01 billion IPO, marking one of the largest listings by a Chinese firm in the U.S. this year.
Octave Intelligence shares fall on investor uncertainty
Stock declines amid broader tech sector volatility and lack of recent corporate updates. Shares down 4% in early trade.
CoreWeave call options surge as traders bet on further upside
Options activity on CoreWeave surged as call volume outpaced puts, signaling bullish bets on the AI infrastructure firm's stock.
Denmark shares rise 0.81% as OMX Copenhagen 20 closes higher
The OMX Copenhagen 20 index advanced 0.81% on Tuesday, tracking broader European equity gains amid stable macro conditions.
Turkey’s BIST 100 rises 2.96% at close of trade
Istanbul benchmark advances as investors weigh policy shifts and global market sentiment.
H.B. Fuller shares fall on weaker-than-expected guidance
Specialty chemicals maker cuts full-year sales outlook, citing softer demand in key end-markets. Shares drop over 5% in early trade.
Mastercard seen outpacing Visa in revenue growth by 2027
Analysts project Mastercard’s revenue growth to exceed Visa’s over the next three years, driven by digital payments expansion and market share gains.
AI stocks drive major indexes toward record highs
S&P 500 and Nasdaq edge closer to all-time peaks on renewed optimism around artificial intelligence and tech earnings. Market breadth remains narrow.
Poland’s WIG30 advances 0.39% to end higher
Poland’s benchmark equity index rose modestly on Tuesday, supported by gains in blue-chip shares.
BlackBerry outlines growth strategy at Canaccord conference
Company highlights progress in software and cybersecurity segments as part of its strategic pivot away from legacy handset business.
Kiniksa outlines Arcalyst growth, pipeline at Canaccord conference
Biotech firm Kiniksa discussed Arcalyst expansion and pipeline advancements during a Canaccord Genuity investor event, emphasizing commercial and R&D progress.
Twilio flags infrastructure gains at Canaccord growth event
Cloud communications firm outlines efficiency gains and margin improvements at investor conference. Shares fluctuate modestly in after-hours trading.